






































































































































































































































































































































































Abbreviation Full Term 
ADMA Asymmetric di-methylarginine  
AdoHcy S-Adenosyl homocysteine  
AdoMet S-Adenosyl methionine 
AdOx Adenosine periodate oxidized 
ADP Adenosine diphosphate 
AMI Arginine methylation inhibitors  
Arg-R Arginine 
APC Adenomatous polyposis coli 
ATP Adenosine triphosphate 
BTG1 B cell translocation gene 1 
BTG2 B cell translocation gene 2 
CARM1 Co-activator associated arginine methyltransferase 1 
CaV2.2 Presynaptic N- type calcium channel 
CDK Cyclin-dependent kinase 
cAMP Cyclic adenosine monophosphate 
CO2 Carbon dioxide 
CREB CAMP responsive element binding protein 
CRMP Collapsin response mediator protein 
Da Dalton  
DCX Doublecortin 
DDAH Di-methylarginine di-methylaminohydrolase 
DHP Dihydropyrimidine  
DNA Deoxyribonucleic acid 
DOCK7 Dedicator of cytokinesis 7 
DRP Dihydropyrimidinase related protein 
ER-α Estrogen receptor α 
EWS Ewing sarcoma 
esiRNA Endo-ribonuclease prepared siRNA 
eV Electron volt 
FBXO F-box only protein 
FACS Fluorescence activated cell sorting 
FSC Forwards scatter 
G0 Resting phase of cell cycle 
G1 First gap phase of cell cycle 
G2 Second gap phase of cell cycle 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GAR Glycine and arginine  
GDP Guanosine-5'-triphosphate 
Gly or G Glycine 
GSK3β Glycogen synthase kinase 3 β 
GTP Guanosine-5'-triphosphate 
	 xii 
Abbreviation Full Term 
Hcy Homocysteine 
His or H Histidine 
HIV Human immunodeficiency virus 
hnRNP Heterogeneous nuclear ribonucleoprotein 
HTLV-1 Human T-lymphotropic virus type 1 
IP Immunoprecipitation 
JMJD6 Jumonji domain-containing protein 6 
kDa Kilo Dalton 
kV Kilo Volt 
L Litres 
LEDGF/P75 Lens epithelium-derived growth factor 
LKB1 Liver kinase B1 
LPA Lysophosphatidic acid 
Lys - K Lysine 
MAP Microtubule associated protein 
MAPKs Mitogen activated protein kinases 
MEP50 Methylosome protein 50 
mg Milligrams 
mL Millilitres 
MLL-EEN Mixed lineage leukaemia fused with extra eleven nineteen gene 
mM Millimolar 
MMDB The Molecular modeling database 
MMA  Mono-methylarginine 
MT Microtubule 
MTP1B Microsomal triglyceride transfer protein 1 B 
mRNA Messenger ribonucleic acid 
MWT Molecular weight 
NC Nucleocaspid 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 




NO Nitric oxide 
NOS Nitric oxide synthase 
°C Degrees Celsius 
OD Optical Density 
PAD4 Peptidyl-arginine deiminase 
PRMT Protein arginine methyltransferases  
PTM Post-translational modification 
QToF Quadrupole time-of-flight 
Rev Regulator of virion 
	 xiii 
Abbreviation Full Term 
RNA Ribonucleic acid  
RPM Revolutions per minute 
SAH S-adenosyl homocysteine 
SAM S-adenosyl methionine 
Sam68 Src-Associated substrate during Mitosis of 68 kDa 
SCG10 Superior cervical ganglia neural-specific 10 protein 
SCLIP SCG10 like proteins 
SDMA Symmetric di-methylarginines  
SEM Standard error of the mean 
Ser - S Serine 
SH3 Src Homology 3 
snRNP Small nuclear ribonucleic proteins 
STDEV Standard deviation 
STRAD STE20-like pseudokinase 
TAR Transactivator Region 
Tat Trans-activator of transcription 
TG Transglutaminase 
TOAD Turned on after Division 
TTL Tubulin tyrosine ligase 
TTLL Tubulin tyrosine ligase like 
TUBA1A Tubulin alpha 1 A chain 
TUBB2B Tubulin beta 2 B chain 
TUBB5 Tubulin beta 5 chain 
TUBBIII Tubulin beta III  
Tyr - Y Tyrosine 
UV Ultraviolet 
vDNA Integrated Viral DNA 
Vif HIV-1 viral infectivity factor 
Vpr HIV-1 viral regulatory protein R 
μg Micrograms 
μL Microlitres 
Ulip UNC33 like protein 
μm Micrometre 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Modification Location Enzyme Function 
Acetylation 
 
Tubulin α Lys40. Inside 
the lumen. Other 





Guidance cue for 
motors. 
Not involved in the 




surface of the polymer 
Unknown 
Carboxypeptidase 







Last 15 residues of C-
terminus of tubulin α 





Regulation of MT 
and the interactions 
with MAPs and 
motor proteins 








Polyamination Q15 on tubulin β and other sites Transglutaminase 
Stabilisation of MT 
in mature axons 
SUMOylation Multiple site on tubulin α and β Unknown 
Intracellular 
trafficking? 
Ubiquitylation Multiple site on tubulin α and β Parkin 
Protein-protein 
interactions? 
















































































































































Materials Abbreviation Supplier 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid HEPES GIBCO
® Invitrogen Australia 
25 mm thick pre-filter paper  Life Technologies, Australia 
25% Trypsin in EDTA 
(Ethylenediaminetetraacetic acid)  GIBCO
® Invitrogen Australia 
96-well plates (flat bottom)  Sigma-Aldrich Australia 
Acetonitrile ACN Sigma-Aldrich Australia 
Adenosine periodate  AdOx Sigma-Aldrich Australia 
Ammonium bicarbonate  NH4HCO3 Sigma-Aldrich Australia 
BCIP/NBT liquid substrate   Sigma-Aldrich Australia 
Bicinchoninic acid BCA Sigma-Aldrich Australia 
Borosilicate glass pipette   Coring - Sigma Aldrich Australia 
Bovine serum albumin powder BSA Sigma-Aldrich Australia 
Cell strainer 70 µM  Corning, Australia 
Chymotrypsin   Promega 
Colloidal brilliant blue stain  Sigma-Aldrich Australia 
Copper (II) Sulfate Cu2SO4 Sigma-Aldrich Australia 
Dimethyl sulfoxide DMSO Sigma-Aldrich Australia 
Dithiothreitol  DTT Sigma-Aldrich Australia 
Dulbecco's modified Eagle's 
medium DMEM GIBCO
® Invitrogen Australia 
Ethanol (absolute)   Sigma-Aldrich Australia 
Extravidin-alkaline phosphatase  ExAP Sigma-Aldrich Australia 
Fetal calf serum  FCS GIBCO® Invitrogen Australia 
Flow cytometer Setup and Tracking 
Beads  CST BD Bioscience 
Formic acid   Sigma-Aldrich Australia 
GenMute transfection Kit for 
Neuro2a   SignaGen Laboratories 
Glutamax   GIBCO® Invitrogen Australia 
Glycerol  Sigma-Aldrich Australia 
HALT Protease Inhibitor (100x) HALT PI Thermo Scientific 
Hank’s balanced salt solution  HBSS GIBCO® Invitrogen Australia 
Iodoacetamide  IAA Sigma-Aldrich Australia 
Methanol  MeOH Sigma-Aldrich Australia 
Mini-protean precast gels 4-20%   Bio-Rad 
Mission esiRNA targeting mouse 
KIF11   Sigma-Aldrich Australia 
Mission esiRNA targeting mouse 
PRMT1   Sigma-Aldrich Australia 
Mission esiRNA targeting mouse 
PRMT8   Sigma-Aldrich Australia 
Neurobasal medium   GIBCO® Invitrogen Australia 
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Materials Abbreviation Supplier 
Nonidet P-40 NP-40  
Page Ruler Plus Prestained Protein 
Ladder   Thermoscientific 
Penicillin-Streptomycin (antibiotic) Pen/Strep GIBCO®  Invitrogen Australia 
Phosphate buffered saline tablets PBS Sigma-Aldrich Australia 
Pierce crosslink IP kit   Thermo Scientific 
Placlitaxal from Taxus brevifolia  Taxol Sigma-Aldrich Australia 
Poly-D-lysine coated 6 and 24 well 
plates  BD biocoat Australia 
Polyvinylidene difluoride membrane PVDF Millipore-Australia 
Propidium iodide PI Sigma-Aldrich Australia 
RNase   Sigma-Aldrich Australia 
Round Bottom Polystyrene Test 
Tube, with Cell Strainer Snap Cap 
(Falcon) 
 Corning, Australia 
Skim milk powder   Coles 
Sodium azide   Sigma-Aldrich Australia 
Trans-2,3-dimethoxy-ß-nitrostyrene PRMT1/8 inhibitor Sigma-Aldrich Australia 
Trifluoroacetic acid TFA Sigma-Aldrich Australia 
Trypan blue   Sigma-Aldrich Australia 
Trypsin-EDTA buffer   GIBCO® Invitrogen Australia 
Trypsin Gold   Promega 
Tubulin, GST tagged (human)  Sigma, NSW, Ausralia 








Buffer Name Use Composition 
10x Phosphate buffered 
saline 
Cell culture and Western 
Blot 
1.8 mM KH2PO4, 138 mM 
NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4.2H2O in dH2O. 
Adjusted pH to 7.4 
5x Laemmli loading dye SDS-PAGE 
0.5 M Tris base, Glycerol (10% 
v/v), 0.028 M SDS, β-
mercaptoethanol (4% v/v) and 
0.15 mM Bromophenol blue in 
dH2O 
BCA colour solution BCA Protein Assay 1:50  CuSO4 : Bicinchoninic acid 
Chymotrypsin working 
solution  
mass spectrometry peptide 
digestion  
10 ng chymotrypsin in 10 mM 
ammonium bicarbonate pH 7.4 
Conditioning buffer Immunoprecipitation 
Propriety solution from Pierce 
Crosslink IP Kit (Product 
#26147)  
DMEM complete Cell Culture and Transient Transfection 
Heat inactivated FCS (10% 
v/v), Penicillin (1000 U/mL), 
Streptomycin (0.1 mg/mL), 
2mM L-Glutamine 
Elution buffer Immunoprecipitation 
Propriety solution from Pierce 
Crosslink IP Kit (Product 
#26147) 
ExtrAvidin - Alkaline 
phosphatase Western Blot 
PBST (10 mL), ExAP (0.02% 
v/v) 
GenMute transfection buffer Neuro2a siRNA transfection 
Propriety solution from 
SignaGen Laboratories, 
transfection kit  
Neurobasal media complete Mouse embryonic neuronal primary cell culture 
1x B27, 0.5 mM L-glutamine, 
25 μM glutamate, 100 IU/mL 
penicillin and 100 μg/mL 
streptomycin  
Phosphate buffered saline + 
Tween 20 (PBST) Western Blot 1x PBS, Tween 20 (0.01% v/v) 
PI staining solution staining cells for flow cytometry analysis 
0.02 mg/mL PI, 0.5 mg/mL 
RNAse A, 5% FCS in PBS 
solution 
Pierce IP wash/lysis buffer Cell lysis, IP columns wash 
25mM Tris-HCl pH 7.4, 150mM 
NaCl, 1mM EDTA, 1% NP-40 
and 5% glycerol, 1x HALT PI 
Primary antibody solution Western Blot PBST (10 mL), Primary Antibody (1% v/v) 
SDS/tris/glycine Running 
Buffer 10x SDS-PAGE 
1.9 M Glycine, 0.25 M Tris 
base, 0.035 M SDS  
Secondary antibody 
solution Western Blot 
PBST (10 mL), Secondary 
Antibody (0.4% v/v) 
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Buffer Name Use Composition 
Skim milk blocking solution Western Blot 5% w/v skim milk powder in PBS 
Transfer buffer (1x) Western Blot 
1:10 of 10x Transfer buffer, 
2:10 MeOH and 7:10 dH2O. 
(Example 10 mL 10x transfer 
buffer, 20 mL MeOH, 70 mL 
dH2O) 
Transfer buffer 10x Western Blot 1.9 M Glycine, 0.25 M Tris base  
Trypsin gold working 
solution 
Mass spectrometry peptide 
digestion  
10 ng trypsin in 10 mM 




Centrifuge 5425-Eppendorf Eppendorf South Pacific, NSW, Australia  
Centrifuge 5810 R-Eppendorf Eppendorf South Pacific, NSW, Australia  
CO2 Water-Jacketed Incubator-NUAIRE In Vitro Technologies, VIC, Australia 
Dissection microscope-Motic  Optic Central, VIC, Australia 
Fitted camera-Leica Leica Microsystems, NSW, Australia 
Haemocytometer Hausser Scientific, PA, USA 
Image station gel scanner 4000nm-Kodak Millennium Science, VIC, Australia 
Light microscope-Leica Leica Microsystems, NSW, Australia 
Mass spectrometer/QToF-Waters Waters, NSW, Australia 
Microplate incubator-Thermostar BMG Labtech, VIC, Australia 
Mini-Protean tetra System Bio-Rad, VIC, Australia 
Nano Aquity C18 BEH130 column  Waters, NSW, Australia 
Nano Aquity UPLC Waters, NSW, Australia 
OWL HEP series semi-dry blotter Thermo Scientific, VIC, Australia 
Pellet pestle Sigma-Aldrich, Australia 
PowerPac HC Bio-Rad, VIC, Australia 
Sonicator-Branson 2510 Consonic, NSW, Australia 
Spectrophotometer-FLUOstar OPTIMA  BMG Labtech, VIC, Australia 
Speed vac concentrator- Savant DNA 120 Thermo Scientific, VIC, Australia 














Alpha tubulin A1 
chain Primary 1:5000 ab18251 Abcam 
Asym24 Primary 1:500 07-414 Millipore 
Beta tubulin III Primary 1:800 ab18207 Abcam 
CRMP-2 Primary 1:10,000 ab62661 Abcam 
KIF11 Primary 1:500 K36382 Sigma-Aldrich Australia 
PRMT1 Primary 1:500 07-404 Millipore 
PRMT5 Primary 1:500 07-405  
PRMT8 Primary 1μg/mL ab168134 Abcam 
Biotinylated anti-
rabbit whole 
molecule goat IgG  
Secondary 1:2500  B7389 
Sigma-Aldrich 
Australia 
Sym10  Primary 1:500 07-412 Millipore 
	
Table	2.5	List	of	esiRNAs	
esiRNA Catalogue Number NCBI accession No. 
Mouse PRMT1 EMU016791 NM_019830 
Mouse PRMT8  EMU055401 NM_201371 


















































































































































































































































































































































































































































































































































































267 Trypsin 50% 
Cortex CRMP-2 NIPRITSDR 11 Trypsin 50% 
Cortex CRMP-2 TIEAHSRMVIPGGIDVHTR 63 Trypsin 75% 
Cortex CRMP-2 
DRFQLSDSQI






238, 270 Chymotrypsin 50% 
Cortex Tubulin α 
AVFVDLEPTV
IDEVR 79 Trypsin 100% 
Cortex Tubulin α 
AVCMLSNTTA
IAEAWAR 390 Trypsin 50% 




62 Chymotrypsin 75% 
Cortex Tubulin β VREEYPDR 156 Trypsin 100% 




241 Trypsin 50% 
Cortex Tubulin β TSRGSQQY 276 Chymotrypsin 50% 
Cortex/
Neuro2a Tubulin β 
RALTVPELTQ
QMF 282 Chymotrypsin 100% 





















































































































































































































































































CRMP-1    1MSHQGKKSIP HITSDRLLIR GGRIINDDQS FYADVYLEDG LIKQIGENLI50  
CRMP-2     MSYQGKKNIP RITSDRLLIK GGKIVNDDQS FYADIYMEDG LIKQIGENLI  
CRMP-3     MSFQGKKSIP RITSDRLLIK GGKIVNDDQS FHADLYVEDG LIKQIGENLI  
 
CRMP-1   51VPGGVKTIEA NGRMVIPGGI DVNTYLQKPS QGMTSADDFF QGTKAALAGG100  
CRMP-2     VPGGVKTIEA HSRMVIPGGI DVHTRFQMPD QGMTSADDFF QGTKAALAGG  
CRMP-3     VPGGIKTIDA HGLMVLPGGV DVHTRLQMPV MGMTPADDFC QGTKAALAGG  
 
CRMP-1  101TTMIIDHVVP EPGSSLLTSF EKWHEAADTK SCCDYSLHVD ITSWYDGVRE150  
CRMP-2     TTMIIDHVVP EPGTSLLAAF DQWREWADSK SCCDYSLHVD ITEWHKGIQE  
CRMP-3     TTMILDHVFP DAGVSLLAAY EQWRERADSA ACCDYSLHVD IPRWHESTKE  
 
CRMP-1  151ELEVLVQDKG VNSFQVYMAY KDLYQMSDSQ LYEAFTFLKG LGAVILVHAE200  
CRMP-2     EMEALVKDHG VNSFLVYMAF KDRFQLTDSQ IYEVLSVIRD IGAIAQVHAE  
CRMP-3     ELEALVRDKG VNSFLVFMAY KDRCQCTDGQ IYEIFSLIRD LGAVAQVHAE  
 
CRMP-1  200NGDLIAQEQK RILEMGITGP EGHALSRPEE LEAEAVFRAI AIAGRINCPV250  
CRMP-2     NGDIIAEEQQ RILDLGITGP EGHVLSRPEE VEAEAVNRSI TIANQTNCPL  
CRMP-3     NGDIVEEEQK RLLEQGITGP EGHVLSHPEE VEAEAVYRAV TIAKQANCPL  
 
CRMP-1  251YITKVMSKSA ADIIALARKK GPLVFGEPIA ASLGTDGTHY WSKNWAKAAA300  
CRMP-2     YVTKVMSKSA AEVIAQARKK GTVVYGEPIT ASLGTDGSHY WSKNWAKAAA  
CRMP-3     YVTKVMSKGA ADMVAQAKRR GVVVFGEPIT ASLGTDGSHY WSKNWAKAAA  
 
CRMP-1  301FVTSPPLSPD PTTPDYLTSL LACGDLQVTG SGHCPYSTAQ KAVGKDNFTL350  
CRMP-2     FVTSPPLSPD PTTPDFLNSL LSCGDLQVTG SAHCTFNTAQ KAVGKDNFTL  
CRMP-3     FVTSPPINPD PTTADHLTSL LSSGDLQVTG SAHCTFTTAQ KAVGKDNFTL  
 
CRMP-1  351IPEGVNGIEE RMTVVWDKAV ATGKMDENQF VAVTSTNAAK IFNLYPRKGR400  
CRMP-2     IPEGTNGTEE RMSVIWDKAV VTGKMDENQF VAVTSTNAAK VFNLYPRKGR  
CRMP-3     IPEGVNGIEE RMSVVWEKCV ASGKMDENEF VAVTSTNAAK IFNFYPRKGR  
 
CRMP-1  401IAVGSDADVV IWDPDKMKTI TAKSHKSTVE YNIFEGMECH GSPLVVISQG450  
CRMP-2     ISVGSDADLV IWDPDSVKTI SAKTHNSALE YNIFEGMECR GSPLVVISQG  
CRMP-3     VAVGSDADLV IWNPRATKVF SAKSHNLNVE YNIFEGVECR GVPTVVISQG  
 
CRMP-1  451KIVFEDGNIS VSKGMGRFIP RKPFPEHLYQ RVRIRSKVFG LHSVSRGMYD500  
CRMP-2     KIVLEDGTLH VTEGSGRYIP RKPFPDFVYK RIKARSRLAE LRGVPRGLYD  
CRMP-3     RVVLEDGNLL VTPGAGRFIP RKTFPDFVYK RIKARNRLAE IHGVPRGLYD  
 
CRMP-1  501GPVYEVPATP KHAAPAPSAK SSPSKHQPPP IRNLHQSNFS LSGAQIDDNN550  
CRMP-2     GPVCEVSVTP KTVTPASSAK TSPAKQQAPP VRNLHQSGFS LSGAQIDDNI  
CRMP-3     GPVHEVMLPA KPGSGTQARA SCSGKISVPP VRNLHQSGFS LSGSQADDHI  
 
CRMP-1  551PRRTGHRIVA PPGGRSNITS LG 
CRMP-2     PRRTTQRIVA PPGGRANITS LG 























































































Tub β4A    1 MREIVHLQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DL—-QLERIN50  
Tub β2B     MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPTGSYHGDS DL—-QLERIN  
Tub β3      MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPSGNYVGDS DL--QLERIS  
Tub β6      MREIVHIQAG QCGNQIGTKF WEVISDEHGI DQAGGYVGDS AL--QLERIS 
Tub α1A     MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN  
Tub α1B     MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN  
Tub α1c     MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN   
Tub α3      MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN  
Tub α8      MRECISVHVG QAGVQIGNAC WELFCLEHGI QADGTFGTQA SKINDDDSFT 
 
Tub β4A    51VYYNEATGGN YVPRAVLVDL EPGTMDSVRS GPFGQIFRPD NFVFGQSGAG100  
Tub β2B     VYYNEATGNK YVPRAILVDL EPGTMDSVRS GPFGQIFRPD NFVFGQSGAG  
Tub β3      VYYNEASSHK YVPRAILVDL EPGTMDSVRS GAFGHLFRPD NFIFGQSGAG 
Tub β6      VYYNESSSKK YVPRAALVDL EPGTMDSVRS GPFGQLFRPD NFIFGQTGAG 
Tub α1A     TFFSETGAGK HVPRAVFVDL EPTVIDEVRT GTYRQLFHPE QLITGKEDAA  
Tub α1B     TFFSETGAGK HVPRAVFVDL EPTVIDEVRT GTYRQLFHPE QLITGKEDAA  
Tub α1c     TFFSETGAGK HVPRAVFVDL EPTVIDEVRT GTYRQLFHPE QLITGKEDAA   
Tub α3      TFFSETGAGK HVPRAVFVDL EPTVVDEVRT GTYRQLFHPE QLITGKEDAA  
Tub α8      TFFSETGNGK HVPRAVMVDL EPTVVDEVRA GTYRQLFHPE QLITGKEDAA 
 
Tub β4A   101NNWAKGHYTE GAELVDAVLD VVRKEAESCD CLQGFQLTHS LGGGTGSGMG150  
Tub β2B       NNWAKGHYTE GAELVDSVLD VVRKESESCD CLQGFQLTHS LGGGTGSGMG  
Tub β3      NNWAKGHYTE GAELVDSVLD VVRKECENCD CLQGFQLTHS LGGGTGSGMG 
Tub β6      NNWAKGHYTE GAELVDSVLD VVRKECENCD CLQGFQLTHS LGGGTGSGMG 
Tub α1A     NNYARGHYTI GKEIIDLVLD RIRKLADQCT GLQGFLVFHS FGGGTGSGFT  
Tub α1B     NNYARGHYTI GKEIIDLVLD RIRKLADQCT GLQGFLVFHS FGGGTGSGFT  
Tub α1c     NNYARGHYTI GKEIIDLVLD RIRKLADQCT GLQGFLVFHS FGGGTGSGFT  
Tub α3      NNYARGHYTI GKEIVDLVLD RIRKLADLCT GLQGFLIFHS FGGGTGSGFA  
Tub α8      NNYARGHYTV GKESIDLVLD RIRKLTDACS GLQGFLIFHS FGGGTGSGFT  
 
Tub β4A   151TLLISKIREE FPDRIMNTFS VVPSPKVSDT VVEPYNATLS VHQLVENTDE200  
Tub β2B      TLLISKIREE YPDRIMNTFS VMPSPKVSDT VVEPYNATLS VHQLVENTDE  
Tub β3      TLLISKVREE FPDRIMNTFS VVPSPKVSDT VVEPYNATLS IHQLVENTDE 
Tub β6      TLLISKIREE FPDRIMNTFS VMPSPKVSDT VVEPYNATLS VHQLVENTDE 
Tub α1A     SLLMERLSVD YGKKSKLEFS IYPAPQVSTA VVEPYNSILT THTTLEHSDC  
Tub α1B     SLLMERLSVD YGKKSKLEFS IYPAPQVSTA VVEPYNSILT THTTLEHSDC 
Tub α1c     SLLMERLSVD YGKKSKLEFS IYPAPQVSTA VVEPYNSILT THTTLEHSDC 
Tub α3      SLLMERLSVD YGKKSKLEFA IYPAPQVSTA VVEPYNSILT THTTLEHSDC 
Tub α8      SLLMERLSLD YGKKSKLEFA IYPAPQVSTA VVEPYNSILT THTTLEHSDC 
 
Tub β4A   201TYCIDNEALY DICFRTLKLT TPTYGDLNHL VSATMSGVTT CLRFPGQLNA250  
Tub β2B      TYCIDNEALY DICFRTLKLT TPTYGDLNHL VSATMSGVTT CLRFPGQLNA  
Tub β3      TYCIDNEALY DICFRTLKLT APTYGDLNHL VSATMSGVTT SLRFPGQLNA 
Tub β6      TYCIDNEALY DICFRTLKLT TPTYGDLNHL VSATMSGVTT SLRFPGQLNA 
Tub α1A     AFMVDNEAIY DICRRNLDIE RPTYTNLNRL IGQIVSSITA SLRFDGALNV  
Tub α1B     AFMVDNEAIY DICRRNLDIE RPTYTNLNRL ISQIVSSITA SLRFDGALNV  
Tub α1c     AFMVDNEAIY DICRRNLDIE RPTYTNLNRL ISQIVSSITA SLRFDGALNV  
Tub α3      AFMVDNEAIY DICRRNLDIE RPTYTNLNRL IGQIVSSITA SLRFDGALNV  
Tub α8      AFMVDNEAIY DICRRNLDIE RPTYTNLNRL ISQIVSSITA SLRFDGALNV 
 
Tub β4A   251DLRKLAVNMV PFPRLHFFMP GFAPLTSRGS QQYRALTVPE LTQQMFDAKN300  
Tub β2B     DLRKLAVNMV PFPRLHFFMP GFAPLTSRGS QQYRALTVPE LTQQMFDSKN  
Tub β3      DLRKLAVNMV PFPRLHFFMP GFAPLTSRGS QQYRALTVPE LTQQMFDAKN 
Tub β6      DLRKLAVNMV PFPRLHFFMP GFAPLTSRGS QQYRALTVPE LTQQMFDAKN 
Tub α1A     DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLSVAE ITNACFEPAN  
Tub α1B     DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLSVAE ITNACFEPAN  
Tub α1c     DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLTVAE ITNACFEPAN  
Tub α3      DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLSVAE ITNACFEPAN  




Tub β4A   301MMAACDPRHG RYLTVAAVFR GRMSMKEVDE QMLSVQSKNS SYFVEWIPNN350  
Tub β2B     MMAACDPRHG RYLTVAAIFR GRMSMKEVDE QMLNVQNKNS SYFVEWIPNN  
Tub β3      MMAACDPRHG RYLTVAAVFR GRMSMKEVDE QMLAIQSKNS SYFVEWIPNN 
Tub β6      MMAACDPRHG RYLTVAAVFR GRMSMKEVDE QMLAIQNKNS SYFVEWIPNN 
Tub α1A     QMVKCDPRHG KYMACCLLYR GDVVPKDVNA AIATIKTKRT IQFVDWCPTG  
Tub α1B     QMVKCDPRHG KYMACCLLYR GDVVPKDVNA AIATIKTKRS IQFVDWCPTG  
Tub α1c     QMVKCDPRHG KYMACCLLYR GDVVPKDVNA AIATIKTKRT IQFVDWCPTG  
Tub α3      QMVKCDPRHG KYMACCMLYR GDVVPKDVNA AIATIKTKRT IQFVDWCPTG   
Tub α8      QMVKCDPRHG KYMACCMLYR GDVVPKDVNV AIAAIKTKRT IQFVDWCPTG  
 
Tub β4A   351VKTAVCDIPP RGL------- -KMAATFIGN STAIQELFKR ISEQFTAMFR400  
Tub β2B       VKTAVCDIPP RGL------- -KMSATFIGN STAIQELFKR ISEQFTAMFR  
Tub β3      VKVAVCDIPP RGL------- -KMSSTFIGN STAIQELFKR ISEQFTAMFR 
Tub β6      VKVAVCDIPP RGL------- -KMASTFIGN STAIQELFKR ISEQFSAMFR 
Tub α1A     FKVGINYQPP TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA  
Tub α1B     FKVGINYQPP TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA   
Tub α1c     FKVGINYQPP TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA  
Tub α3      FKVGINYQPP TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA  
Tub α8      FKVGINYQPP TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA  
 
Tub β4A   401RKAFLHWYTG EGMDEMEFTE AESNMNDLVS EYQQYQGATA –EEGE-FEEE450  
Tub β2B     RKAFLHWYTG EGMDEMEFTE AESNMNDLVS EYQQYQDATA DEQGE-FEEE  
Tub β3      RKAFLHWYTG EGMDEMEFTE AESNMNDLVS EYQQYQDATA EEEGEMYEDD 
Tub β6      RKAFLHWYTG EGMDEMEFTE AESNMNDLVS EYQQYQDATV NDGEEAFEDE 
Tub α1A     KRAFVHWYVG EGMEEGEFSE AREDMAALEK DYEEVGVDSV --EGEGEEEG  
Tub α1B       KRAFVHWYVG EGMEEGEFSE AREDMAALEK DYEEVGVDSV --EGEGEEEG  
Tub α1c     KRAFVHWYVG EGMEEGEFSE AREDMAALEK DYEEVGADSA --EG--DDEG  
Tub α3      KRAFVHWYVG EGMEEGEFSE AREDLAALEK DYEEVGVDSV --EAE-AEEG  
Tub α8      KRAFVHWYVG EGMEEGEFSE AREDLAALEK DYEEVGTDSF --EEE--NEG  
 
Tub β4A   451AEEEVA---- 
Tub β2B      EGEDEA----  
Tub β3      DEESEAQGPK  
Tub β6      DEEINE---- 
Tub α1A     EEY------- 
Tub α1B     EEY------- 
Tub α1c     EEY------- 
Tub α3      EEY—------ 
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G1 S G2/M 
1 DMSO 44.1 43 10.2 
1 DMSO 34.8 52 9.83 
1 Taxol 34 5.3 57.5 
1 Taxol 31 11 54 
1 Both 4 17.4 67 
1 AdOx 28 55 8 
1 AdOx 22 63 10 
2 DMSO 40 44 14 
2 DMSO 39 35 16 
2 Taxol 16 12 65 
2 Taxol 23 9 67 
2 Taxol and AdOx 10 15 71 
2 Taxol and AdOx 8 13.5 65 
2 AdOx 12 75 8 
2 AdOx 20 52 2 
3 DMSO 50 39 10 
3 DMSO 43 35 14 
3 Taxol 24 27 41 
3 Taxol 25 28 38 
3 Taxol and AdOx 21 24 52 
3 Taxol and AdOx 22 24 54 
3 AdOx 11 84 5 
3 AdOx 13.5 82 6 
4 DMSO 52 39 4 
4 DMSO 55 32 10 
4 Taxol 20 13 63 
4 Taxol 23 10 65 
4 Taxol and AdOx 10 6 77 
4 Taxol and AdOx 11 12 75 
4 AdOx 10.8 62.4 24.1 
4 AdOx 12 55 20 
5 DMSO 72 13 13 
5 DMSO 73 15 10 
5 Taxol 21 12.4 54.3 
5 Taxol 10.6 13 55 
5 Taxol and AdOx 8 13 70 






G1 S G2/M 
5 AdOx 24 41 20 
5 AdOx 24 43 18 
6 DMSO 75 15 12 
6 DMSO 77 18 0 
6 Taxol 21 37 43 
6 Taxol 23 39 40 
6 Taxol and AdOx 23 9 77 


















Repeat # Control AdOx 
1 3505.16 1621.889 
2 2060 528.388 
 Tubulin α 
Repeat # Control AdOx 
1 3758.401 3123.338 
2 1508.539 1575.459 
 Asym24/ Tubulin α 
Repeat # Control AdOx 
1 0.932620016 0.519280654 
2 1.365559657 0.335386703 
















Repeat # Control AdOx 
1 3500.19 1003.62 
2 2941.061 1506.06 
 Tubulin β 
Repeat # Control AdOx 
1 1696.163 1291.991 
2 1523.7096 1585.6166 
 Asym24/Tubulin β 
Repeat # Control AdOx 
1 2.063592945 0.776801077 
2 1.930197854 0.94982608 










Treatment Axonal Length (µm) Cell body area (µm2) 
1 Control 122.64 311.765 
2 Control 100.787 331.401 
3 Control 98.117 211.332 
4 Control 116.126 265.225 
5 Control 122.114 352.855 
6 Control 76.014 303.633 
7 Control 44.796 333.91 
8 Control 76.081 197.232 
9 Control 90.867 297.405 
10 Control 109.208 313.062 
11 Control 100.97 255.969 
12 Control 174.764 311.505 
13 Control 232.494 337.63 
14 Control 331.066 399.135 
15 Control 217.669 204.239 
16 Control 217.665 227.336 
17 Control 154.547 327.595 
18 Control 106.081 339.446 
19 Control 176.26 451.99 
20 Control 267.357 310.208 
21 Control 116.429 267.647 
22 Control 335.854 348.183 
23 Control 37.915 300.173 
24 Control 101.739 290.571 
25 Control 77.141 283.651 
26 Control 47.314 310.208 
27 Control 44.216 267.647 
28 Control 227.911 348.183 
29 Control 210.116 300.173 
30 Control 217.942 290.571 
31 Control 142.941 283.651 
32 Control 263.545 276.99 
33 Control 122.177 323.875 
34 Control 182.039 270.761 
35 Control 185.056 307.093 
36 Control 85.031 297.664 
37 Control 151.685 370.242 
38 Control 166.288 263.754 
39 Control 170.184 262.63 




Treatment Axonal Length (µm) Cell body area (µm2) 
41 Control 121.742 294.031 
42 Control 131.861 290.484 
43 Control 47.746 429.412 
44 Control 123.421 273.356 
45 Control 78.547 348.097 
46 Control 247.425 281.142 
47 Control 208.877 247.232 
48 Control 295.556 350.865 
49 Control 199.128 266.609 
50 Control 126.072 233.737 
51 Control 83.482 286.851 
52 Control 71.638 278.201 
53 Control 98.898 314.273 
54 Control 40.241 321.453 
55 Control 134.613 233.737 
56 Control 147.824 286.851 
57 Control 176.139 278.201 
58 Control 120.913 314.273 
59 Control 227.703 321.453 
60 Control 137.823 441.003 
61 Control 181.573 291.522 
62 Control 117.705 239.706 
63 Control 110.341 265.138 
64 Control 139.662 368.772 
65 Control 126.914 238.581 
66 Control 141.057 340.398 
67 Control 141.231 266.696 
68 Control 173.349 445.761 
69 Control 164.886 352.855 
70 Control 191.339 392.993 
71 Control 250.578 456.834 
72 Control 336.753 360.813 
73 Control 233.273 343.166 
74 Control 229.882 297.059 
75 Control 163.049 274.913 
76 Control 81.249 237.803 
77 Control 117.719 393.339 
78 Control 167.352 266.955 
79 Control 269.875 253.633 
80 Control 167.055 257.266 
81 Control 172.829 375.346 
82 Control 91.564 342.042 
83 Control 249.564 289.706 
84 Control 238.218 330.623 




Treatment Axonal Length (µm) Cell body area (µm2) 
86 Control 184.430 330.277 
87 Control 147.980 309.602 
88 Control 268.421 336.851 
89 Control 171.555 369.723 
90 Control 111.015 348.875 
91 Control 95.458 383.997 
92 Control 115.22 375.26 
93 Control 81.722 343.426 
94 Control 211.959 386.592 
95 Control 174.362 286.505 
96 Control 174.835 266.955 
97 Control 177.323 253.633 
98 Control 110.962 257.213 
99 Control 210.474 392.993 
100 Control 51.674 456.834 
101 Control 238.591 360.813 
102 Control 145.58 238.571 
103 Control 87.743 340.698 
104 Control 134.943 346.842 
105 Control 102.453 395.891 
106 AdOx (25µM) 41.778 291.696 
107 AdOx (25µM) 65.424 299.870 
108 AdOx (25µM) 46.703 450.000 
109 AdOx (25µM) 62.223 379.152 
110 AdOx (25µM) 35.018 304.412 
111 AdOx (25µM) 41.274 272.880 
112 AdOx (25µM) 51.808 465.182 
113 AdOx (25µM) 43.887 263.669 
114 AdOx (25µM) 76.754 280.017 
115 AdOx (25µM) 79.451 312.197 
116 AdOx (25µM) 43.523 242.648 
117 AdOx (25µM) 73.344 219.551 
118 AdOx (25µM) 27.605 267.431 
119 AdOx (25µM) 10.081 212.933 
120 AdOx (25µM) 10.746 216.437 
121 AdOx (25µM) 27.418 248.616 
122 AdOx (25µM) 27.658 366.306 
123 AdOx (25µM) 19.170 382.266 
124 AdOx (25µM) 8.937 413.409 
125 AdOx (25µM) 14.004 217.475 
126 AdOx (25µM) 30.415 369.551 
127 AdOx (25µM) 21.606 359.559 
128 AdOx (25µM) 11.427 313.106 
129 AdOx (25µM) 7.633 323.357 




Treatment Axonal Length (µm) Cell body area (µm2) 
131 AdOx (25µM) 116.735 339.707 
132 AdOx (25µM) 28.217 313.625 
133 AdOx (25µM) 43.561 298.703 
134 AdOx (25µM) 69.262 302.726 
135 AdOx (25µM) 36.590 336.722 
136 AdOx (25µM) 80.122 238.625 
137 AdOx (25µM) 93.446 260.424 
138 AdOx (25µM) 25.764 315.182 
139 AdOx (25µM) 72.871 263.409 
140 AdOx (25µM) 79.005 316.350 
141 AdOx (25µM) 33.755 300.000 
142 AdOx (25µM) 50.0316 401.471 
143 AdOx (25µM) 87.923 380.45 
144 AdOx (25µM) 76.941 389.274 
145 AdOx (25µM) 91.899 305.450 
146 AdOx (25µM) 38.507 350.217 
147 AdOx (25µM) 75.238 315.572 
148 AdOx (25µM) 32.802 305.321 
149 AdOx (25µM) 123.223 488.798 
150 AdOx (25µM) 108.780 305.321 
151 AdOx (25µM) 66.050 488.798 
152 AdOx (25µM) 80.090 314.144 
153 AdOx (25µM) 88.060 368.642 
154 AdOx (25µM) 115.120 346.194 
155 AdOx (25µM) 87.160 358.781 
156 AdOx (25µM) 68.220 223.659 
157 AdOx (25µM) 65.570 393.167 
158 AdOx (25µM) 136.140 505.536 
159 AdOx (25µM) 101.170 209.732 
160 AdOx (25µM) 182.360 254.152 
161 AdOx (25µM) 80.490 395.243 
162 AdOx (25µM) 50.790 380.969 
163 AdOx (25µM) 130.220 254.844 
164 AdOx (25µM) 126.183 399.783 
165 AdOx (25µM) 40.174 327.553 
166 AdOx (25µM) 11.022 392.388 
167 AdOx (25µM) 90.594 324.914 
168 AdOx (25µM) 52.341 455.061 
169 AdOx (25µM) 55.131 430.926 
170 AdOx (25µM) 95.568 356.705 
171 AdOx (25µM) 80.932 327.899 
172 AdOx (25µM) 65.110 298.572 
173 AdOx (25µM) 41.643 386.289 
174 AdOx (25µM) 23.527 382.526 




Treatment Axonal Length (µm) Cell body area (µm2) 
176 AdOx (25µM) 162.651 448.443 
177 AdOx (25µM) 89.323 363.063 
178 AdOx (25µM) 92.854 378.633 
179 AdOx (25µM) 49.275 246.150 
180 AdOx (25µM) 42.416 330.148 
181 AdOx (25µM) 26.750 408.996 
182 AdOx (25µM) 55.110 199.017 
183 AdOx (25µM) 158.893 370.848 
184 AdOx (25µM) 147.459 294.464 
185 AdOx (25µM) 160.743 304.975 
186 AdOx (25µM) 86.432 249.222 
187 AdOx (25µM) 140.033 303.591 
188 AdOx (25µM) 118.113 259.732 
189 AdOx (25µM) 121.757 273.097 
190 AdOx (25µM) 93.065 359.688 
191 AdOx (25µM) 114.825 324.914 
192 AdOx (25µM) 126.144 255.061 
193 AdOx (25µM) 96.983 330.926 
194 AdOx (25µM) 39.680 356.705 
195 AdOx (25µM) 63.361 327.899 
196 AdOx (25µM) 105.683 398.572 
197 AdOx (25µM) 45.434 314.144 
198 AdOx (25µM) 51.366 368.642 
199 AdOx (25µM) 96.535 346.194 
200 AdOx (25µM) 68.160 358.781 
201 AdOx (25µM) 58.664 323.659 
202 AdOx (25µM) 81.734 293.167 
203 AdOx (25µM) 66.722 215.536 
204 AdOx (25µM) 99.320 287.573 
205 AdOx (25µM) 59.178 212.266 
206 AdOx (25µM) 31.221 207.308 
207 AdOx (25µM) 51.925 362.333 
208 AdOx (25µM) 62.577 301.358 
209 AdOx (25µM) 72.000 335.667 









 Control (x1000) 
Repeat # Live Dead 
1 530 115 
2 405 95 
3 500 110 
4 365 90 
Average 450 102.5 
STDEV 77.78 11.90 
SEM 38.89 5.95 
 AdOx (x1000) 
Repeat # Live Dead 
1 190 50 
2 155 75 
3 210 55 
4 185 50 
Average 185 57.5 
STDEV 22.73 11.90 



















Repeat # Control AdOx 
1 7266.841 2722.477 
2 9858.347 3963.326 
3 8901.154 3519.962 
Tubulin β 
Repeat # Control AdOx 
1 5984.648 2655.284 
2 6570.79 1933.284 
3 5478.255 2236.305 
CRMP-2 
Repeat # Control AdOx 
1 6311.154 6298.447 
2 4273.577 5017.941 
3 2815.92 3313.698 
Tubulin α/CRMP 
Repeat # Control AdOx 
1 1.151428249 0.432245758 
2 2.306813941 0.789831128 
3 3.161010966 1.062245865 
Average 2.206417719 0.761440917 
STDEV 1.008546095 0.315958125 
SEM 0.582284359 0.182418509 
Tubulin β/CRMP 
Repeat # Control AdOx 
1 0.948265246 0.421577573 
2 1.537538694 0.385274359 
3 1.945458323 0.674866871 
Average 1.477087421 0.493906267 
STDEV 0.501337487 0.157764178 















 Control esiRNA Control esiRNA Control esiRNA 
Repeat # PRMT1 PRMT8 KIF11 
1 5644.43 1776.77 2647.75 702.41 1642.75 988.11 
2 1715.04 707.34 6445.18 1320.82 2570.92 264.97 
3 5310.01 1763.48 6127.06 4885.72 7735.84 4322.89 
 GAPDH 
Repeat # PRMT1 PRMT8 KIF11 
1 1081.70 1325.11 1004.82 812.11 3744.94 4139.16 
2 411.68 379.09 3665.50 3298.50 3657.70 3943.92 
3 2305.72 2674.48 2063.00 1948.45 3112.75 3298.94 
 RPRMT/GAPDH 
Repeat # PRMT1 PRMT8 KIF11 
1 5.22 1.34 2.64 0.86 0.44 0.24 
2 4.17 1.87 1.76 0.40 0.70 0.07 
3 2.30 0.66 2.97 2.51 2.49 1.31 
Average 3.90 1.29 2.45 1.26 1.21 0.54 
STDEV 1.48 0.60 0.63 1.11 1.11 0.67 

















Band at 55 kDa 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 468.80 551.21 226.85 111.90 
2 974.80 525.09 578.97 254.14 
3 776.11 627.65 504.92 172.85 
Band at 70 kDa 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 1261.50 1607.91 663.52 292.58 
2 439.63 450.11 319.99 226.63 
3 690.41 638.69 664.11 153.82 
Band at 130 kDa 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 1017.65 968.34 313.82 293.73 
2 613.63 465.53 317.58 262.26 
3 655.00 644.27 342.66 179.46 
GAPDH 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 4084.60 5156.89 5246.89 5525.53 
2 6160.21 4508.59 5158.40 6186.62 





Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 0.11 0.11 0.04 0.02 
2 0.16 0.12 0.11 0.04 
3 0.30 0.32 0.23 0.04 
Average 0.19 0.18 0.13 0.04 
STDEV 0.10 0.12 0.10 0.01 
SEM 0.06 0.07 0.06 0.01 
70 kDa/GAPDH 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 0.31 0.31 0.13 0.05 
2 0.07 0.10 0.06 0.04 
3 0.27 0.33 0.31 0.04 
Average 0.22 0.25 0.17 0.04 
STDEV 0.13 0.13 0.13 0.01 
SEM 0.07 0.07 0.07 0.01 
130 kDa/GAPDH 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 0.25 0.19 0.06 0.05 
2 0.10 0.10 0.06 0.04 
3 0.25 0.33 0.16 0.05 
Average 0.20 0.21 0.09 0.05 
STDEV 0.09 0.11 0.06 0.01 
















Repeat # Control esiRNA PRMT1/8 
1 2267.477 1109.335 
2 2663.761 1336.761 
3 513.584 318.424 
Tubulin α 
Repeat # Control esiRNA PRMT1/8 
1 4563.82 4708.991 
2 5784.335 6030.284 
3 2054.335 2273.698 
Asym24/ Tubulin α 
Repeat # Control esiRNA PRMT1/8 
1 0.50 0.24 
2 0.46 0.22 
3 0.25 0.14 
Average 0.40 0.20 
STDEV 0.13 0.05 














 Tubulin α 
Repeat # Control PRMT1 PRMT8 
1 22096.439 20765.125 20740.468 
2 5430.062 6270.77 6012.376 
3 8722.065 7542.120 7704.014 
 Asym24 
Repeat # Control PRMT1 PRMT8 
1 3210.598 2586.062 2640.648 
2 4996.770 4518.527 5338.841 
3 3728.134 4572.093 3313.105 
 Asym24/Tubulin α 
Repeat # Control PRMT1 PRMT8 
1 0.14529934 0.124538716 0.127318631 
2 0.920204963 0.720569723 0.887975236 
3 0.427437081 0.606207936 0.430049193 
Average 0.497647128 0.483772125 0.48178102 
STDEV 0.39219481 0.316316513 0.382957901 




















 Tubulin α 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 2534.13 6198.50 9710.50 6969.79 
2 3641.96 2689.38 5574.50 2621.96 
3 986.58 1440.70 4354.18 1732.36 
 CRMP-2 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 2449.41 3222.70 3211.46 3357.28 
2 2314.58 3121.99 1981.99 2927.82 
3 2182.82 2507.62 1734.39 2683.43 
 Tubulin α/CRMP-2 
Repeat # Control PRMT1 KD PRMT8 KD PRMT1/8 KD 
1 1.49 1.92 3.02 2.08 
2 1.09 0.86 3.21 0.90 
3 0.45 0.57 2.51 0.65 
Average 1.01 1.12 2.92 1.21 
STDEV 0.52 0.71 0.36 0.76 








  Phase (%) Folds 
Repeat # Treatment G1 S G2/M G1 S G2/M 
1 DMSO 75 15 12 1.00 1.00 1.00 
1 Inhibitor 36 53 7 0.48 3.53 0.58 
1 taxol 21 37 43 0.28 2.47 3.58 
2 DMSO 77 18 11 1.00 1.00 1.00 
2 Inhibitor 38 36 14 0.49 2.00 1.27 
2 taxol 23 39 40 0.30 2.17 3.64 
3 DMSO 72 13 13 1.00 1.00 1.00 
3 Inhibitor 59 30 6 0.82 2.31 0.46 
3 taxol 21 12.4 54.3 0.29 0.95 4.18 
4 DMSO 73 15 10 1.00 1.00 1.00 
4 Inhibitor 39 33 17 0.53 2.20 1.70 
4 taxol 10.6 13 55 0.27 0.39 3.24 
5 DMSO 38 49 9 1.00 1.00 1.00 
5 Inhibitor 38 53 7 1.00 1.08 0.78 
5 taxol 11 35 39 0.29 0.66 5.57 
6 DMSO 39 50 10 1.00 1.00 1.00 
6 Inhibitor 39 47 9 1.00 0.94 0.90 






Repeat # Live Dead 
1 2955 75 
2 2065 20 
3 2505 50 
Average 2508.33 48.33 
STDEV 445.01 27.54 
SEM 256.93 15.90 
1 µM PRMT1/8 inhibitor 
Repeat # Live Dead 
1 1740 165 
2 1995 35 
3 2025 75 
Average 1920.00 91.67 
STDEV 156.60 66.58 
SEM 90.42 38.44 
1.5 µM PRMT1/8 inhibitor 
Repeat # Live Dead 
1 1305 85 
2 1445 70 
3 1225 65 
Average 1325.00 73.33 
STDEV 111.36 10.41 
SEM 64.29 6.01 
2 µM PRMT1/8 inhibitor 
Repeat # Live Dead 
1 145 470 
2 160 745 
3 110 550 
Average 138.33 588.33 
STDEV 25.66 141.45 







































































Repeat # Control 24hr 48hr 72hr 
1 312.849 463.092 1395.627 2414.619 
2 559.506 506.749 335.335 2897.255 
3 890.799 853.042 946.456 6137.397 
PRMT8 
Repeat # Control 24hr 48hr 72hr 
1 1403.092 1841.092 1121.092 1393.021 
2 808.989 2260.749 1481.456 1756.406 
3 680.08 1267.356 738.77 1855.982 
PRMT1 
Repeat # Control 24hr 48hr 72hr 
1 2986.87 2920.598 3873.012 5104.376 
2 5390.64 4574.74 4433.619 8388.175 
3 3444.77 3403.891 3892.891 5999.719 
GAPDH 
Repeat # Control 24hr 48hr 72hr 
1 3971.782 4696.782 3271.782 4513.641 
2 3101.841 3622.184 4063.033 4181.246 








Repeat # Control 24hr 48hr 72hr 
1 0.078767918 0.098597721 0.426564789 0.534960357 
2 0.180378685 0.139901507 0.082533172 0.692916657 
3 0.236707131 0.176834642 0.18853615 1.33554706 
Average 0.165284578 0.138444623 0.232544704 0.854474691 
STDEV 0.080044193 0.039138802 0.176187409 0.424040701 
SEM 0.046213536 0.022596798 0.101721848 0.244820013 
 PRMT8/GAPDH 
Repeat # Control 24hr 48hr 72hr 
1 0.353265109 0.39199009 0.342654859 0.308624678 
2 0.260809306 0.624139746 0.364618254 0.420067607 
3 0.180713927 0.262721465 0.147164635 0.403876644 
Average 0.264929448 0.426283767 0.284812583 0.377522976 
STDEV 0.086349344 0.183133382 0.119711386 0.060214354 
SEM 0.049853817 0.105732107 0.069115401 0.034764774 
 PRMT1/GAPDH 
Repeat # Control 24hr 48hr 72hr 
1 0.752022644 0.621829585 1.183762243 1.13087771 
2 1.73788405 1.262978358 1.091209203 2.006142427 
3 0.915359834 0.705622754 0.775472587 1.305587218 
Average 1.135088842 0.863476899 1.016814678 1.480869118 
STDEV 0.528385566 0.348505933 0.214070128 0.463211496 
SEM 0.305063549 0.201209994 0.123593446 0.267435282 
	
	
